Describes a protein engineering method that uses nitric oxide-triggered decaging of masked amino acids to restore protein function selectively in inflamed tissues.
Key Takeaways
- 2: Characterization of NO-responsive activation in engineered antibody and luciferase
- 5: NO-responsive AAV enables gene transduction specifically in inflamed liver
- Any additional raw data and materials are available from the corresponding author (T.L.) on reasonable request